Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$1.65 CAD
Change Today +0.03 / 1.85%
Volume 5.8K
As of 4:11 PM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Xavier Harland BSc Act, CFA, FRM

Former Chief Financial Officer of Acasti Pharma, Neptune Technologies & Bioressources, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

----
As of Fiscal Year 2014

Background*

Mr. Xavier Harland, BSc Act, CFA, FRM, served as the Chief Financial Officer of Acasti Pharma Inc. from March 21, 2011 to June 13, 2014. Mr. Harland served as a Director of Finance at Neptune Technologies & Bioresources, Inc. since 2004. Mr. Harland is an actuary, a Chartered Financial Analyst (“CFA”) charterholder and Financial Risk Manager (“FRM”) holder. He graduated in Actuarial Science from Laval University in 2003.

Corporate Headquarters*

545 Promenade du Centropolis
Laval, Quebec H7T 0A3

Canada

Phone: 450-687-2262
Fax: 450-687-2272

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education 2003
Université Laval

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NTB:CN C$1.65 CAD +0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Philip C. Mezey Chief Executive Officer, President and Director
Itron, Inc.
$800.0K
Richard A. Meeusen Chairman, Chief Executive Officer and President
Badger Meter Inc.
$1.4M
Ariel Katz Chief Executive Officer and President
Enzymotec Ltd.
$301.0K
Andrzej Szostak President of the Management Board
Apator Spólka Akcyjna
971.0K
Kim Giffoni Chief Executive Officer and Director
Targeted Medical Pharma, Inc.
$484.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEPTUNE TECH & BIORESSOURCES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.